‌

Actions

Action Type

‌
‌

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Overview

Detailed Summary

Insecticides (India) Limited is a leading agrochemical company focused on the manufacturing and distribution of a wide range of crop protection products including insecticides, herbicides, and fungicides.
In the recent years, IIL has significantly advanced its R&D capabilities through collaborations with global players like Nissan and Corteva, launching innovative and high-margin products.
The company has shown marked improvement in its financial performance with a focus on premiumization and expansion which propelled an increase in B2C premium product share to 61% by FY25.
Strategic capacity expansions at its manufacturing facilities and the acquisition of Kaeros Research Ltd. enhance IIL's supply chain and operational efficiency, ensuring better market competitiveness.
IIL has a robust strategic plan to maintain double-digit growth through targeted product launches and strategic tie-ups, aiming for long-term sustainability and market leadership.

Sector: Fertilizers & Agrochemicals
Industry: Pesticides & Agrochemicals
Market Cap: 2,101 Cr
Volatility: Low Risk
P/E Ratio: 13.8
Industry P/E: 22.6
PEG Ratio: 0.7
P/B Ratio: 1.8
52W High: 1,096.30
52W Low: 525.90

Sales CAGR

1Y: 1.71%
3Y: 10.01%
5Y: 7.99%
10Y: 7.46%

Profit CAGR

1Y: 39.14%
3Y: 9.31%
5Y: 10.19%
10Y: 15.14%

ROE

TTM: 12.34%
3Y: 10.19%
5Y: 10.81%
10Y: 12.00%

ROCE

TTM: 14.63%
3Y: 14.13%
5Y: 14.74%
10Y: 17.05%

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
BHAGCHEM		216.00	2,855 Cr	203.77	4.14	0.07	1.77	3.31	1.27
BHARATRAS		1548.50	2,583 Cr	11.42	2.16	0.02	11.13	14.06	9.12
INSECTICID		671.00	2,101 Cr	13.79	1.75	0.28	12.34	14.63	7.09
IPL		155.25	1,790 Cr	16.12	1.87	0.48	10.91	15.14	8.67
ASTEC		649.20	1,619 Cr	-16.05	3.91	0.00	-27.52	-7.48	-10.10
MOL		47.30	1,364 Cr	29.75	0.89	0.00	2.58	7.27	1.23
PUNJABCHEM		951.30	1,306 Cr	19.43	3.27	0.28	13.08	16.21	8.67
Median: 7 Co.	—	649.20	1,790 Cr	16.12	2.16	0.07	10.91	14.06	7.09

Financial Statements

Upcoming Result Date: May 27, 2026

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Consolidated Quarterly Results (in ₹ Crores)

View Standalone

Total Figures

QoQ Changes

Total Figures

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	696	358	273	657	627	358	359	691	638	385
Expenses	614	332	264	585	538	327	330	607	548	358
Operating Profit	82	26	8.96	72	90	31	28	85	89	27
OPM %	11.77	7.27	3.29	10.89	14.28	8.64	7.93	12.24	14.03	7.12
Other Income	0.03	1.27	4.48	2.70	1.69	0.38	2.86	3.91	2.87	1.00
Interest	2.86	2.79	2.07	1.63	1.69	1.41	2.14	3.72	4.16	4.68
Depreciation	7.35	7.42	7.60	7.13	7.25	7.58	7.17	7.31	9.33	9.41
Profit Before Tax	72	17	3.77	65	82	22	22	77	79	14
Tax %	25.92	27.94	-106.10	25.10	25.29	22.08	36.92	24.98	25.04	26.64
Net Profit	53	12	7.76	49	61	17	14	58	59	10
EPS in Rs	18.26	4.23	2.67	16.84	21.14	5.96	4.77	19.97	20.31	3.60

Consolidated Profit Loss (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1,076	1,106	1,194	1,363	1,420	1,504	1,801	1,966	2,000	2,035
Expenses	883	925	1,006	1,207	1,268	1,334	1,679	1,804	1,779	1,801
Operating Profit	193	181	187	156	152	170	122	163	221	234
OPM %	17.97	16.36	15.68	11.43	10.73	11.28	6.77	8.27	11.06	11.48
Other Income	7.13	3.56	1.15	3.44	-1.50	4.68	1.50	9.78	7.57	8.84
Interest	20	16	15	24	6.65	6.63	13	11	6.86	8.96
Depreciation	16	17	20	24	25	26	26	29	29	29
Profit Before Tax	82	118	153	111	120	141	84	132	193	204
Tax %	27.43	28.82	19.95	21.93	21.42	24.01	24.60	22.56	26.33	26.07
Net Profit	60	84	123	87	94	107	63	102	142	151
EPS in Rs	—	—	42.21	29.87	32.27	34.12	16.58	35.17	48.71	48.65
Dividend Payout %	6.93	4.90	3.37	9.51	4.40	8.29	14.04	8.67	4.13	—

Consolidated Balance Sheet (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	21	21	21	21	21	21	20	30	30	29
Reserves	388	444	527	641	711	800	850	889	984	1,055
Borrowings	181	221	105	296	189	100	54	163	87	105
Other Liabilities	347	292	347	397	374	505	473	615	613	709
Total Liabilities	936	978	1,000	1,356	1,294	1,426	1,396	1,696	1,713	1,898
Fixed Assets	198	185	232	240	239	239	253	262	282	279
CWIP	51	58	17	19	39	59	91	123	142	161
Investments	3.14	11	17	12	12	14	16	18	22	32
Other Assets	684	725	735	1,084	1,004	1,115	1,037	1,294	1,268	1,426
Total Assets	936	978	1,000	1,356	1,294	1,426	1,396	1,696	1,713	1,898

Consolidated Cash Flows (in ₹ Crores)

View Standalone

Total Figures

YoY Changes

Total Figures

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity	86	4.01	182	-133	242	155	135	-11	184	93
Cash from Investing Activity	-19	-14	-26	-49	-24	-113	9.31	-86	-43	-38
Cash from Financing Activity	-64	9.36	-143	172	-159	-104	-115	80	-98	-61
Net Cash Flow	3.50	-0.27	13	-11	59	-61	30	-17	43	-5.36

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	72.16%	72.16%	72.16%	72.16%	72.16%	72.16%	72.16%	72.30%	72.30%	72.30%	72.30%	72.30%
FIIs	6.46%	6.02%	5.19%	4.42%	4.32%	4.36%	5.43%	5.13%	4.49%	4.66%	4.51%	4.46%
DIIs	10.79%	10.55%	9.41%	9.13%	9.16%	9.09%	9.08%	9.24%	9.59%	9.72%	9.50%	9.40%
Public	10.60%	11.28%	13.25%	14.29%	14.37%	14.39%	13.34%	13.34%	13.62%	13.32%	13.69%	13.85%
Total Shareholders	16,355	18,012	18,868	18,232	19,252	19,474	22,485	22,849	22,688	21,436	22,336	22,359

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q3 FY26

Investor Presentation

Q2 FY26

Investor Presentation

Q1 FY26

Available on Pro Plan